{"PubmedArticle": [{"MedlineCitation": {"SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "OtherAbstract": [], "CitationSubset": ["IM"], "KeywordList": [], "GeneralNote": [], "PMID": "19384952", "DateCompleted": {"Year": "2009", "Month": "08", "Day": "04"}, "DateRevised": {"Year": "2021", "Month": "10", "Day": "20"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1002/ijc.24325"], "Journal": {"ISSN": "1097-0215", "JournalIssue": {"Volume": "125", "Issue": "4", "PubDate": {"Year": "2009", "Month": "Aug", "Day": "15"}}, "Title": "International journal of cancer", "ISOAbbreviation": "Int J Cancer"}, "ArticleTitle": "Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells.", "Pagination": {"StartPage": "774", "EndPage": "782", "MedlinePgn": "774-82"}, "Abstract": {"AbstractText": ["Epidemiologic evidence suggests that a diet rich in fruits and vegetables is associated with a reduced risk of prostate cancer (PCa) development. Although several dietary compounds have been tested in preclinical PCa prevention models, no agents have been identified that either prevent the progression of premalignant lesions or treat advanced disease. Momordica charantia, known as bitter melon in English, is a plant that grows in tropical areas worldwide and is both eaten as a vegetable and used for medicinal purposes. We have isolated a protein, designated as MCP30, from bitter melon seeds. The purified fraction was verified by SDS-PAGE and mass spectrometry to contain only 2 highly related single chain Type I ribosome-inactivating proteins (RIPs), alpha-momorcharin and beta-momorcharin. MCP30 induces apoptosis in PIN and PCa cell lines in vitro and suppresses PC-3 growth in vivo with no effect on normal prostate cells. Mechanistically, MCP30 inhibits histone deacetylase-1 (HDAC-1) activity and promotes histone-3 and -4 protein acetylation. Treatment with MCP30 induces PTEN expression in a prostatic intraepithelial neoplasia (PIN) and PCa cell lines resulting in inhibition of Akt phosphorylation. In addition, MCP30 inhibits Wnt signaling activity through reduction of nuclear accumulation of beta-catenin and decreased levels of c-Myc and Cyclin-D1. Our data indicate that MCP30 selectively induces PIN and PCa apoptosis and inhibits HDAC-1 activity. These results suggest that Type I RIPs derived from plants are HDAC inhibitors that can be utilized in the prevention and treatment of prostate cancer."]}, "AuthorList": [{"AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Hematology and Tumor Biology Research, First Affiliated Hospital of Wenzhou Medical College, Wenzhou, China."}], "Identifier": [], "LastName": "Xiong", "ForeName": "Su Dao", "Initials": "SD"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Yu", "ForeName": "Kang", "Initials": "K"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Liu", "ForeName": "Xin Hua", "Initials": "XH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Yin", "ForeName": "Li Hui", "Initials": "LH"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Kirschenbaum", "ForeName": "Alexander", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Yao", "ForeName": "Shen", "Initials": "S"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Narla", "ForeName": "Goutham", "Initials": "G"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "DiFeo", "ForeName": "Analisa", "Initials": "A"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Wu", "ForeName": "Jian Buo", "Initials": "JB"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Yuan", "ForeName": "Yong", "Initials": "Y"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Ho", "ForeName": "Shuk-Mei", "Initials": "SM"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Lam", "ForeName": "Ying Wai", "Initials": "YW"}, {"AffiliationInfo": [], "Identifier": [], "LastName": "Levine", "ForeName": "Alice C", "Initials": "AC"}], "GrantList": [{"GrantID": "R01CA015776", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "ES015584", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R01 CA015776", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "P30ES006096", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}, {"GrantID": "R01 CA062269", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "R01CA112532", "Acronym": "CA", "Agency": "NCI NIH HHS", "Country": "United States"}, {"GrantID": "P30 ES006096", "Acronym": "ES", "Agency": "NIEHS NIH HHS", "Country": "United States"}], "PublicationTypeList": ["Journal Article", "Research Support, N.I.H., Extramural", "Research Support, Non-U.S. Gov't", "Research Support, U.S. Gov't, Non-P.H.S."]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "Int J Cancer", "NlmUniqueID": "0042124", "ISSNLinking": "0020-7136"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Histone Deacetylase Inhibitors"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Proteins"}, {"RegistryNumber": "0", "NameOfSubstance": "RNA, Messenger"}, {"RegistryNumber": "EC 1.13.12.-", "NameOfSubstance": "Luciferases"}, {"RegistryNumber": "EC 2.7.11.1", "NameOfSubstance": "Proto-Oncogene Proteins c-akt"}, {"RegistryNumber": "EC 3.1.3.67", "NameOfSubstance": "PTEN Phosphohydrolase"}, {"RegistryNumber": "EC 3.2.2.22", "NameOfSubstance": "Ribosome Inactivating Proteins"}, {"RegistryNumber": "EC 3.5.1.98", "NameOfSubstance": "HDAC1 protein, human"}, {"RegistryNumber": "EC 3.5.1.98", "NameOfSubstance": "Histone Deacetylase 1"}, {"RegistryNumber": "EC 3.5.1.98", "NameOfSubstance": "Histone Deacetylases"}], "CommentsCorrectionsList": [{"RefSource": "Int J Cancer. 2009 Oct 15;125(8):1995"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["drug effects"], "DescriptorName": "Apoptosis"}, {"QualifierName": [], "DescriptorName": "Blotting, Western"}, {"QualifierName": [], "DescriptorName": "Cell Cycle"}, {"QualifierName": [], "DescriptorName": "Diet"}, {"QualifierName": [], "DescriptorName": "Enzyme-Linked Immunosorbent Assay"}, {"QualifierName": [], "DescriptorName": "Flow Cytometry"}, {"QualifierName": [], "DescriptorName": "Histone Deacetylase 1"}, {"QualifierName": [], "DescriptorName": "Histone Deacetylase Inhibitors"}, {"QualifierName": ["metabolism"], "DescriptorName": "Histone Deacetylases"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Immunoblotting"}, {"QualifierName": [], "DescriptorName": "In Situ Nick-End Labeling"}, {"QualifierName": ["metabolism"], "DescriptorName": "Luciferases"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Nude"}, {"QualifierName": ["chemistry"], "DescriptorName": "Momordica charantia"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "PTEN Phosphohydrolase"}, {"QualifierName": [], "DescriptorName": "Phosphorylation"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Plant Proteins"}, {"QualifierName": ["enzymology", "pathology"], "DescriptorName": "Precancerous Conditions"}, {"QualifierName": ["genetics", "metabolism", "pathology"], "DescriptorName": "Prostatic Intraepithelial Neoplasia"}, {"QualifierName": ["enzymology", "pathology"], "DescriptorName": "Prostatic Neoplasms"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "Proto-Oncogene Proteins c-akt"}, {"QualifierName": ["genetics", "metabolism"], "DescriptorName": "RNA, Messenger"}, {"QualifierName": [], "DescriptorName": "Reverse Transcriptase Polymerase Chain Reaction"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Ribosome Inactivating Proteins"}, {"QualifierName": [], "DescriptorName": "Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization"}]}, "PubmedData": {"ReferenceList": [{"ReferenceList": [], "Reference": [{"Citation": "ACS. Cancer facts and figures. Atlanta, GA: ACS; 2006."}, {"Citation": "Sakr WA, Ward C, Grignon DJ, Haas GP. Epidemiology and molecular biology of early prostatic neoplasia. Mol Urol. 2000;4:109\u201313.", "ArticleIdList": ["11062364"]}, {"Citation": "Liu X-H, Kirschenbaum A, Lu M, Yao S, Klausner A, Preston C, Holland JF, Levine AC. Prostaglandin E2 stimulates prostatic intraepithelial neoplasia cell growth through activation of the interleukin-6/GP130/STAT-3 signaling pathway. Biochem Biophy Res Comm. 2002;290:249\u201355.", "ArticleIdList": ["11779161"]}, {"Citation": "Abrams H, Spiro R, Godstein N. Metastases in carcinoma. Cancer. 1950;3:74\u201385.", "ArticleIdList": ["15405683"]}, {"Citation": "Jacobs SC. Spread of prostatic carcinoma to bone. Urology. 1983;21:337\u201344.", "ArticleIdList": ["6340324"]}, {"Citation": "Tamguney T, Stokoe D. New insights into PTEN. J Cell Sci. 2007;120:4071\u20139.", "ArticleIdList": ["18032782"]}, {"Citation": "Mulholland DJ, Dedhar S, Wu H, Nelson CC. PTEN and GSK3\u03b2: key regulators of progression to androgen-independent prostate cancer. Oncogene. 2006;25:329\u201337.", "ArticleIdList": ["16421604"]}, {"Citation": "Pan L, Lu J, Wang X, Han L, Zhang Y, Han S, Huang B. Histone deacetylase inhibitor trichostatin A potentiates doxorubicin-induced apoptosis by up-regulating PTEN expression. Cancer. 2007;109:1676\u201388.", "ArticleIdList": ["17330857"]}, {"Citation": "Chen CS, Weng S-C, Tseng P-H, Lin H-P, Chen C-S. Histone acetylation-independent effect of histone deacetylase inhibitors on Akt through the reshuffling of protein phosphastase 1 complexes. J Biol Chem. 2005;280:38879\u201387.", "ArticleIdList": ["16186112"]}, {"Citation": "Lin RJ, Sternsdorf T, Tini M, Evans RM. Transcriptional regulation in acute promyelocytic leukemia. Oncogene. 2001;20:7204\u201315.", "ArticleIdList": ["11704848"]}, {"Citation": "Halkidou K, Halkidou K, Gaughan L, Cook S, Leung HY, David E, Neal DE, Robson CN. Upregulation and nuclear recruitment of HDAC1 in hormone-refractory prostate cancer. Prostate. 2004;59:177\u201389.", "ArticleIdList": ["15042618"]}, {"Citation": "Choi JH, Kwon HJ, Yoon BI, Kim JH, Han SU, Joo HJ, Kim DY. Expression profile of histonce deacetylase I in gastric cancer tissues. Jpn J Cancer Res. 2001;92:1300\u20134.", "ArticleIdList": ["PMC5926683", "11749695"]}, {"Citation": "Wilson AJ, Byun DS, Popova N, Murray LB, L\u2019Italien K, Sowa Y, Arango D, Velcich A, Augenlicht LH, Mariadason JM. Histone deacetylase 3 (HDAC3) and other class I HDACs regulate colon cell maturation and p21 expression and are deregulated in human colon cancer. J Biol Chem. 2006;281:13548\u201358.", "ArticleIdList": ["16533812"]}, {"Citation": "Pandolfi PP. Histone deacetylases and transcriptional therapy with their inhibitors. Cancer Chemother Pharmacol. 2001;48(Supp 1):S17\u2013S19.", "ArticleIdList": ["11587360"]}, {"Citation": "Bolden JE, Peart MJ, Johnstone RW. Anticancer activities of histone deactylase inhibitors. Nat Rev Drug Discov. 2006;5:769\u201384.", "ArticleIdList": ["16955068"]}, {"Citation": "Bruxvoort KJ, Charbonneua HM, Giambernardi TA, Goolsby JC, Qian C-N, Zylstra CR, Robinson DR, Roy-Burman P, Shaw AK, Buckner-Berghuis Sigler RE, Resau JH, Sullivan R, et al. Inactivation of Apc in the mouse prostate causes prostate carcinoma. Cancer Res. 2007;67:2490\u20136.", "ArticleIdList": ["17363566"]}, {"Citation": "Nusse R. The Wnt gene homepage. 2005 Available at:  http://www.stanford.edu/~rnusse/wntwindow.html."}, {"Citation": "Yang M, Waterman ML, Brachmann RK. hADA2a and hADA3 are required for acetylation, transcriptional activity and proliferative effects of \u03b2-catenin. Cancer Biol Ther. 2007;7:120\u201328.", "ArticleIdList": ["18059173"]}, {"Citation": "Kim E, Lee W-J, Choi K-Y. The PI3 kinase-Akt pathway mediates Wnt3a-induced proliferation. Cell Signal. 2007;19:511\u201318.", "ArticleIdList": ["17011750"]}, {"Citation": "Gang D, Hawke D, Zheng Y, Xia Y, Meisenhelder J, Nika H, Mills GB, Kobayashi R, Hunter T, Lu Z. Phosphorylation of \u03b2-catenin by AKT promotes \u03b2-catenin transcriptional activity. J Biol Chem. 2007;282:11221\u20139.", "ArticleIdList": ["PMC1850976", "17287208"]}, {"Citation": "Zhao H, Cui Y, Dupont J, Sun H, Henningausen L, Yakar S. Over-expression of the tumor suppressor gene phosphatase and tensin homologue partially inhibits Wnt-1-induced mammary tumorigenesis. Cancer Res. 2005;65:6864\u201373.", "ArticleIdList": ["16061670"]}, {"Citation": "Persad S, Troussard AA, McPhee TR, Mulholand D, Dedhar S. Tumor suppressor PTEN inhibits nuclear accumulation of \u03b2-catenin and T cell/lymphoid enhancer factor-1 mediated transcriptional activation. J Cell Biol. 2001;153:1161\u201373.", "ArticleIdList": ["PMC2192018", "11402061"]}, {"Citation": "Bordonaro M, Lazarova DL, Sartorelli AC. The activation of \u03b2-catenin by Wnt signaling mediates the effects of histone deacetylase inhibitors. Exp Cell Res. 2007;313:1652\u201366.", "ArticleIdList": ["PMC3919021", "17359971"]}, {"Citation": "Neuhouser ML. Dietary flavonoids and cancer risk: evidence from human population studies. Nutr Cancer. 2004;50:107.", "ArticleIdList": ["15572291"]}, {"Citation": "Mentor-Marcel R, Lamartiniere CA, Eltoum IE, Greenberg NM, Elgavis A. Genistein in the diet reduces the incidence of poorly differentiated prostatic adenocarcinoma in transgenic mice (TRAMP) Cancer Res. 2001;61:6777\u201382.", "ArticleIdList": ["11559550"]}, {"Citation": "Shukla S, MacLennan GT, Flask CA, Fu P, Mishra A, Resnick MI, Gupta S. Blockade of \u03b2-catenin signaling by plant flavonoid apigenin suppresses prostate carcinogenesis in TRAMP mice. Cancer Res. 2007;67:6925\u201335.", "ArticleIdList": ["17638904"]}, {"Citation": "Lee-Huang S, Huang PL, Nara PL, Chen H-C, Kung H, Huang H, Huang PL. MAP30: a new inhibitor of HIV-1 infection and replication. FEBS. 1990;272:12\u201318.", "ArticleIdList": ["1699801"]}, {"Citation": "Li SC. Pen Ts\u2019ao Kang Mu (Chinese pharmaceutical compendium) Beijing: People\u2019s Medical Publishing House; 1977."}, {"Citation": "Grover JK, Yadav SP. Pharmacological actions and potential uses of Momordica charantia: a review. J Ethnopharmacol. 2004;93:123\u201332.", "ArticleIdList": ["15182917"]}, {"Citation": "Krawinkel MB, Keding GB. Bitter gourd (Momordica charantia): a dietary approach to hyperglycemia. Nutr Rev. 2006;64:331\u20137.", "ArticleIdList": ["16910221"]}, {"Citation": "Kohno H, Yasui Y, Suzuki R, Hosokawa H, Miyashita K, Tanaka T. Dietary seed oil rich in conjugated linoleic acid from bitter melon inhibits azoxymethane-induced rat colon carcinogenesis through elevation of colonic PPAR\u03b3 expression and alteration of lipid composition. Int J Cancer. 2004;110:896\u2013901.", "ArticleIdList": ["15170673"]}, {"Citation": "Lee-Huang S, Huang PL, Sun Y, Chen H-C, Kung H-F, Huang PL, Murphy WL. Inhibition of MDA-MD-231 human breast tumor xenografts and HER2 expression by anti-tumor agents GAP31 and MAP30. Anticancer Res. 2000;20:653\u201360.", "ArticleIdList": ["10810336"]}, {"Citation": "Wang M, Liu A, Garcia FU, Rhim JS, Stearn ME. Growth of HPV-18 immortalized human prostatic intraepithelial neoplasia cell line, influence of IL-10, follistatin, activin-A and DHT. Int J Oncol. 1999;14:1185\u201395.", "ArticleIdList": ["10339677"]}, {"Citation": "Barbieri L, Zamboni M, Lorenzoni E, Montanaro L, Sperti S, Stirpe F. Inhibition of protein synthesis in vitro by proteins from the seeds of Momordica charantia (bitter pear melon) Biochem J. 1980;186:443\u201352.", "ArticleIdList": ["PMC1161595", "7378061"]}, {"Citation": "Ye GJ, Qian R, Lu B, Gu X, Jin S, Wang Q. Isolation, purification and charachterization of a protein from bitter malon seeds. Acta Chim Sinica. 1998;56:1135\u201344."}, {"Citation": "Lam YW, Mobley JA, Evans JE, Carmody JF, Ho S-M. Mass profiling-directed isolation and identification of a stage-specific serologic protein biomarker of advanced prostate cancer. Proteomics. 2005;5:2927\u201338.", "ArticleIdList": ["15952230"]}, {"Citation": "Lam YW, Tam NC, Evans JE, Green KM, Zhang X, Ho S-M. Differential proteomics in the aging noble rat ventral prostate. Proteomics. 2008;8:2750\u201363.", "ArticleIdList": ["PMC4482334", "18546156"]}, {"Citation": "Liu XH, Kirchenbaum A, Lu M, Yao S, Holland JF, Levine AC. Prostaglandin E2 induces hypoxia inducible factor-1\u03b1 protein stabilization and nuclear localization in a human prostate cancer cell line. J Biol Chem. 2002;277:50081\u20136.", "ArticleIdList": ["12401798"]}, {"Citation": "Rose DP, Connolly JM, Meschter CL. Effect of dietary fat on human breast cancer growth and metastasis in nude mice. J Natl Cancer Inst. 1991;83:1491\u20135.", "ArticleIdList": ["1920496"]}, {"Citation": "Liu XH, Kirschenbaum A, Yao S, Lee R, Holland JF, Levine AC. Inhibition of cyclooxygenase-2 suppresses angiogenesis and the growth of prostate cancer in vivo. J Urol. 2000;164:820\u201325.", "ArticleIdList": ["10953162"]}, {"Citation": "Staal FJ, Noort M, Strous GJ, Clevers HC. Wnt signals are transmitted through N-terminally dephosphorylated \u03b2-catenin. EMBO Rep. 2002;3:63\u20138.", "ArticleIdList": ["PMC1083921", "11751573"]}, {"Citation": "Dobosy JR, Roberts JLW, Fu VS, Jarrard DF. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia. J Urol. 2007;177:822\u201331.", "ArticleIdList": ["17296351"]}, {"Citation": "Yasui Y, Hosokawa M, Sahara T, Suzuki R, Ohgiya S, Cono H, Tanaka T, Miyashita K. Bitter gourd seed fatty acid rich in 9c,11t,13t-conjugated linolenic acid induces apoptosis and up-regulates the GADD45, p53 and PPAR\u03b3 in human colon cancer Caco-2 cells. Prostaglandins Leukot Essent Fatty Acids. 2005;73:113\u201319.", "ArticleIdList": ["15961301"]}, {"Citation": "Fong WP, Mock WY, Ng TB. Intrinsic ribonuclease activities in ribonuclease and ribosome-inactivating proteins from the seeds of bitter gourd. Int J Biochem Cell Biol. 2000;32:571\u20137.", "ArticleIdList": ["10736572"]}, {"Citation": "Lee-Huang S, Huang PL, Chen H, Huang PL, Bourinbaiar A, Huang HI, Kung H. Anti-HIV and anti-tumor activities of recombinant MAP30 from bitter melon. Gene. 1995;161:151\u20136.", "ArticleIdList": ["7665070"]}, {"Citation": "Sikriwal D, Ghosh P, Batra JK. Ribsome inactivating protein saporin induces apoptosis through mitochondrial cascade, independent of translation inhibition. Int J Biochem Cell Biol. 2008;40:2880\u20138.", "ArticleIdList": ["18611444"]}, {"Citation": "Chan WY, Huang H, Tam S-C. Receptor-mediated endocytosis of trichosanthin in choriocarcinoma cells. Toxicology. 2003;186:191\u2013203.", "ArticleIdList": ["12628312"]}, {"Citation": "Drummond DC, Nobel CO, Guo Z, Scott GK, Benz CC. Clinical development of histone deacetylase inhibitors as anti-cancer agents. Ann Rev Pharmacol Toxicol. 2005;45:495\u2013528.", "ArticleIdList": ["15822187"]}, {"Citation": "Kikuno N, Shiina H, Urakami S, Kawamoto K, Hirata H, Tanaka Y, Majid S, Igawa M, Dahiya R. Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int J Cancer. 2008;123:552\u201360.", "ArticleIdList": ["18431742"]}, {"Citation": "Li X, Yin S, Meng Y, Sakr W, Sheng S. Endogenous inhibition of histone deacetylase1 by tumor-suppressive maspin. Cancer Res. 2006;66:9323\u20139.", "ArticleIdList": ["16982778"]}, {"Citation": "Khalkhali-Ellis Z. Maspin: The new frontier. Clin Cancer Res. 2006;24:7279\u201383.", "ArticleIdList": ["PMC3175762", "17189399"]}]}], "History": [{"Year": "2009", "Month": "4", "Day": "23", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "4", "Day": "23", "Hour": "9", "Minute": "0"}, {"Year": "2009", "Month": "8", "Day": "6", "Hour": "9", "Minute": "0"}, {"Year": "2013", "Month": "9", "Day": "20"}], "PublicationStatus": "ppublish", "ArticleIdList": ["19384952", "NIHMS481677", "PMC3778503", "10.1002/ijc.24325"]}}], "PubmedBookArticle": []}